Search research articles
Contact Us
Filters
Showing results (441-450 of 628) with videos related to
Page
of 63
Sort By:
Kidney International Reports
|
April 30, 2025
Corrigendum to "Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy" [Volume 10, Issue 1, January 2025, Pages 217-226]
Hiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Journal of Clinical Medicine
|
October 3, 2018
Acute Kidney Injury in Pregnancy: The Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Prevention and Care of Pregnancy-Related AKI, in the Year Dedicated to Women and Kidney Diseases
Giorgina Barbara Piccoli, Elena Zakharova, Rossella Attini, et al.
Diabetes, Obesity & Metabolism
|
March 28, 2023
Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial
Tae Won Yi, Michelle M Y Wong, Brendon L Neuen, et al.
BMJ (Clinical Research Ed.)
|
January 31, 2013
Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis
Dorothea Nitsch, Morgan Grams, Yingying Sang, et al.
Kidney International
|
February 14, 2014
Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar
Chi Pang Wen, Kunihiro Matsushita, Josef Coresh, et al.
Journal of the American Society of Nephrology : JASN
|
September 4, 2024
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses
Tariq Jamal Siddiqi, David Cherney, Hasan Fareed Siddiqui, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 31, 2023
Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial
Sjoukje van der Hoek, Niels Jongs, Megumi Oshima, et al.
Kidney International
|
April 11, 2021
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
Jodie L Babitt, Michele F Eisenga, Volker H Haase, et al.
The Lancet. Diabetes & Endocrinology
|
October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
Megumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials
Megumi Oshima, Luke Buizen, Niels Jongs, et al.
Page
of 63
Search research articles
Search
Showing results (441-450 of 628) with videos related to
Sort By:
Page
of 63
Kidney International Reports
|
April 30, 2025
Corrigendum to "Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy" [Volume 10, Issue 1, January 2025, Pages 217-226]
Hiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Journal of Clinical Medicine
|
October 3, 2018
Acute Kidney Injury in Pregnancy: The Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Prevention and Care of Pregnancy-Related AKI, in the Year Dedicated to Women and Kidney Diseases
Giorgina Barbara Piccoli, Elena Zakharova, Rossella Attini, et al.
Diabetes, Obesity & Metabolism
|
March 28, 2023
Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial
Tae Won Yi, Michelle M Y Wong, Brendon L Neuen, et al.
BMJ (Clinical Research Ed.)
|
January 31, 2013
Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis
Dorothea Nitsch, Morgan Grams, Yingying Sang, et al.
Kidney International
|
February 14, 2014
Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar
Chi Pang Wen, Kunihiro Matsushita, Josef Coresh, et al.
Journal of the American Society of Nephrology : JASN
|
September 4, 2024
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses
Tariq Jamal Siddiqi, David Cherney, Hasan Fareed Siddiqui, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 31, 2023
Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial
Sjoukje van der Hoek, Niels Jongs, Megumi Oshima, et al.
Kidney International
|
April 11, 2021
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
Jodie L Babitt, Michele F Eisenga, Volker H Haase, et al.
The Lancet. Diabetes & Endocrinology
|
October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
Megumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials
Megumi Oshima, Luke Buizen, Niels Jongs, et al.
Page
of 63